Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension
Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension
This is a three-arm pragmatic randomized controlled trial to test two interventions targeting
 clinical inertia in hypertension compared to control, followed by predictive modeling to
 identify factors that are associated with intervention responsiveness. Study investigators
 will use EHR data to identify providers of patients whose hypertension treatment was not
 intensified. Primary care physicians will then be randomized to one of three arms: pharmacist
 e-detailing, provider dashboards, or no intervention (control). After the intervention, the
 investigators will conduct virtual interviews with select providers from each arm. A
 predictive modeling approach will then be used to identify patient and provider
 characteristics that are associated with inertia and with responsiveness to each
 intervention.
Inclusion Criteria:

 -  Primary care physician

 -  Practicing in primary care at Massachusetts General Hospital

 -  Caring for at least 10 patients: (1) aged 18-79, (2) for whom the average of their
 most recent 3 blood pressure measurements in the last 18 months is above goal, (3)
 whose most recent BP at an outpatient visit was above goal, and (4) who did not have
 their hypertension treatment regimens intensified (dose increase, new medication, or
 medication exchange) at or since that time. The BP goal will be <140/90 for patients
 aged 18-59 and <150/90 for patients aged 60-79, consistent with MGH population health
 metrics.

 Exclusion Criteria:

 -None